LATEST ISSUE
November/December 2024
For almost half a century, the principal measure of value in cost-effectiveness analysis has been the quality-adjusted life year (QALY). Several organizations have offered frameworks that include additional value dimensions not captured by the QALY.
VOL. 7, NO. 6
November/December 2021
Finding the Best and Brightest: Getting a Leg Up on the Race for Talent
Vol. 7, No. S2
September 2021
Patients Versus Process: The Data and the Drivers Behind Patient-Centered Outcomes
VOL. 7, NO. 2 S1
March 2021
Valuing Future Alzheimer's Disease Treatments: The Need for a Holistic Approach
VOL. 6, NO. 6
November/December 2020
Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
VOL. 6 NO. 1